Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Honda’s Biggest Flex Isn’t Its Superbikes, It’s Selling 500K Bikes In One Month - 2‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- 3New India programme supports tribal families hosting tourists
- 4Passover under fire: Israelis balance fatigue with cautious hope after month of war
- 5Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- Exemplary Fragrances: A Manual for Notorious Scents
- 10 Demonstrated Systems to Develop Your Internet based Business
- Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
- Unsold Rams May Be Less expensive Than You Suspect
- The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs
- My Excursion to Monetary Autonomy: Awesome ways to save cash
- RSF attack on Sudan’s South Kordofan kills at least 14, including children
- Inside the alleged Russian operation to trigger anti-government protests in Angola
